Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Generate Biomedicines, Inc. - Common Stock (NQ:GENB)

14.28 -0.74 (-4.93%)
Delayed Quote Updated: 2:46 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 656,903
Open 14.79
Bid (Size) 14.27 (200)
Ask (Size) 14.29 (300)
Prev. Close 15.02
Today's Range 14.14 - 14.99
52wk Range 11.00 - 22.67
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer
From Generate Biomedicines, Inc.
Via GlobeNewswire
News headline image
Generate Biomedicines Inc. to Participate in September Investor Conferences
From Generate Biomedicines, Inc.
Via GlobeNewswire

Performance

YTD
+12.9%
+12.9%
1 Month
-6.5%
-6.5%
3 Month
-13.5%
-13.5%
6 Month
+7.3%
+7.3%
1 Year
+12.9%
+12.9%

More News

Read More
News headline image
Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update
From Generate Biomedicines, Inc.
Via GlobeNewswire
News headline image
This Is Nvidia CEO Jensen Huang's Favorite Biotech Stock -- and You've Probably Never Heard of It ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Nvidia CEO Jensen Huang Said AI's "Most Profound Impact Will Be in Life Sciences." Does This Bet on a Biotech Stock Prove He Means It? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Cathie Wood Likes That New Stock Smell: 3 IPO Stocks She Bought on Monday ↗
Via The Motley Fool
Topics ETFs Initial Public Offering
News headline image
Nvidia Owns This Under-the-Radar $20 Stock Poised to Disrupt a $1.8 Trillion Market ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
A New $21 Million Position Signals Confidence in This Post-IPO Drug Developer ↗
Via The Motley Fool
Topics Initial Public Offering
News headline image
A Deep Dive Into NVIDIA’s Latest Portfolio Moves ↗
Via MarketBeat
Topics Artificial Intelligence Economy Regulatory Compliance
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
Via The Motley Fool

Frequently Asked Questions

Is Generate Biomedicines, Inc. - Common Stock publicly traded?
Yes, Generate Biomedicines, Inc. - Common Stock is publicly traded.
What exchange does Generate Biomedicines, Inc. - Common Stock trade on?
Generate Biomedicines, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Generate Biomedicines, Inc. - Common Stock?
The ticker symbol for Generate Biomedicines, Inc. - Common Stock is GENB on the Nasdaq Stock Market
What is the current price of Generate Biomedicines, Inc. - Common Stock?
The current price of Generate Biomedicines, Inc. - Common Stock is 14.28
When was Generate Biomedicines, Inc. - Common Stock last traded?
The last trade of Generate Biomedicines, Inc. - Common Stock was at 10/01/26 02:46 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.